Clinical Trial

X4 Pharmaceuticals to Present Trial-in-Progress Poster on Phase 3 Study of Mavorixafor in Chronic Neutropenia at 66th ASH Annual Meeting & Exposition

Pivotal Phase 3 4WARD clinical trial is evaluating use of oral mavorixafor as monotherapy and in combination with injectable G-CSFBOSTON,…

3 weeks ago

Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a Broad Range of…

3 weeks ago

Liom Cracks “Holy Grail” of Non-Invasive Glucose Monitoring and Secures USD >25m in Funding Kickstarting Its Series A

Liom, formerly known as Spiden, a pioneer in non-invasive biomarker monitoring aiming to develop the first non-invasive glucose monitoring wearable,…

3 weeks ago

Ensysce Biosciences Announces 1-for-15 Reverse Stock Split

SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage…

3 weeks ago

Hemostemix Announces $2,725,982 Update to Second Closing

Calgary, Alberta--(Newsfile Corp. - December 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is…

3 weeks ago

CEFALY Technology Announces New Research Registry to Study eTNS Migraine Treatment in Pregnancy

DARIEN, Conn., Dec. 3, 2024 /PRNewswire/ -- Medical device maker CEFALY Technology today launched the CEFALY Pregnancy Registry, a new…

3 weeks ago

Hollywood Futurist Ted Schilowitz Joins Novobeing as Strategic Investor and Executive Team Member

BOSTON, Dec. 3, 2024 /PRNewswire/ -- Novobeing,a leader in medical virtual reality for enhanced patient care, is proud to welcome…

3 weeks ago

Oshi Health Named to CB Insights 2024 Digital Health 50 List of Most Innovative Digital Health Startups

Oshi Health earns spot for innovative hybrid care that gives patients immediate access to high-quality multidisciplinary digestive health clinicians NEW…

3 weeks ago

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

The Acquisition of NexGenAI Affiliates Network Expands Company's Capabilities and Drives Innovation, Operational Efficiency, and Opportunity for Growth WEXFORD, Pa. ,…

3 weeks ago